###begin article-title 0
###xml 86 90 <span type="species:ncbi:10090">mice</span>
Characterisation of the expression and function of the GM-CSF receptor alpha-chain in mice
###end article-title 0
###begin p 1
###xml 537 542 <span type="species:ncbi:10090">mouse</span>
###xml 567 572 <span type="species:ncbi:10090">mouse</span>
###xml 731 736 <span type="species:ncbi:9606">human</span>
###xml 753 758 <span type="species:ncbi:10090">mouse</span>
###xml 967 972 <span type="species:ncbi:10090">mouse</span>
###xml 1127 1131 <span type="species:ncbi:10090">mice</span>
The granulocyte-macrophage colony-stimulating factor (GM-CSF) is a hematopoietic cytokine able to regulate a variety of cell functions including differentiation of macrophages and granulocytes, dendritic cell development and the maintenance of homeostasis. It binds specifically to its receptor, which is composed of a cytokine-specific alpha-chain (GM-CSF receptor alpha-chain, GMRalpha) and a beta-chain shared with the receptors for interleukin-3 and interleukin-5. In this report, we present a comprehensive study of GMRalpha in the mouse. We have found that the mouse GMRalpha is polymorphic and alternatively spliced. In the absence of specific antibodies, we generated a novel chimeric protein containing the Fc fragment of human IgG1 coupled to mouse GM-CSF, which was able to specifically bind to GMRalpha and induce proliferation of GMRalpha-transduced Ba/F3 cells. We used this reagent to perform the first detailed FACS study of the surface expression of mouse GMRalpha by leucocytes. Highest expression was found on monocytes and granulocytes, and variable expression on tissue macrophages. The GM-CSF receptor in mice is specifically expressed by myeloid cells and is useful for the detection of novel uncharacterised myeloid populations. The ability to detect GM-CSF receptor expression in experimental studies should greatly facilitate the analysis of its role in immune pathologies.
###end p 1
###begin title 2
Introduction
###end title 2
###begin p 3
###xml 254 255 254 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b1">1</xref>
###xml 422 423 422 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b1">1</xref>
###xml 474 475 474 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b2">2</xref>
###xml 592 593 592 593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b3">3</xref>
###xml 766 767 766 767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b4">4</xref>
###xml 774 775 774 775 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 794 795 794 795 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b5">5</xref>
###xml 813 814 813 814 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6">6</xref>
###xml 845 846 845 846 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b7">7</xref>
###xml 850 851 850 851 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b8">8</xref>
###xml 870 871 870 871 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b9">9</xref>
###xml 86 91 <span type="species:ncbi:10090">mouse</span>
###xml 219 224 <span type="species:ncbi:10090">mouse</span>
The granulocyte-macrophage colony-stimulating factor (GM-CSF) was first isolated from mouse lung cell-conditioned media as a small glycoprotein (24-33 kDa) able to generate both macrophage and granulocyte colonies from mouse bone marrow precursor cells [1]. However, a variety of studies have shown other relevant functions including its capacity to enhance host defense mechanisms against bacterial and fungal infection [1], its contribution to dendritic cell development [2], and its involvement in the catabolism of pulmonary surfactant to maintain homeostasis in the alveoli of the lung [3]. GM-CSF can modulate effector functions not only on myeloid cells but also on other cell types expressing the GM-CSF receptor including type II alveolar epithelial cells [4], CD34+ progenitor cells [5], uterine cells [6], vascular endothelial cells [7], [8] and fibroblasts [9].
###end p 3
###begin p 4
###xml 228 230 210 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b10">10</xref>
###xml 583 585 551 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b11">11</xref>
###xml 589 591 557 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b12">12</xref>
###xml 816 818 767 769 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b13">13</xref>
###xml 822 824 773 775 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b14">14</xref>
###xml 600 605 <span type="species:ncbi:10090">mouse</span>
GM-CSF binds specifically to its receptor, which is composed of a cytokine-specific alpha-chain (GM-CSF receptor alpha chain, GMRalpha) and beta-chain (betac), which is shared with the receptors for interleukin (IL)-3 and IL-5 [10]. It associates with GMRalpha with low affinity and rapid dissociation kinetics, but the formation of the alphabeta heterodimeric complex mediates a stable interaction with high affinity and slow dissociation kinetics. Besides enhancing cytokine binding, the betac plays a key role in signal transduction, which can also be modulated by IL-3 and IL-5 [11], [12] In the mouse, there are two homologous betac, AIC2A and AIC2B. IL-3 can induce the formation of the alphabeta complex using either AIC2A or AIC2B, but only AIC2B is able to create the alphabeta complex for GM-CSF and IL-5 [13], [14].
###end p 4
###begin p 5
###xml 657 659 653 655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b11">11</xref>
###xml 663 665 659 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15">15</xref>
###xml 875 877 871 873 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b10">10</xref>
###xml 25 30 <span type="species:ncbi:10090">mouse</span>
###xml 144 149 <span type="species:ncbi:9606">human</span>
Molecular cloning of the mouse GMRalpha cDNA revealed a single transmembrane polypeptide of 387 amino acids with relatively low homology to its human counterpart (less than 35%). It is a type I membrane protein subdivided into three regions: an extracellular domain, a transmembrane region, and a cytoplasmic domain. The extracellular domain shares conserved structural features of the cytokine receptor superfamily containing three fibronectin type III (FN-III)-like domains, four cysteine residues involved in heterodimerization of the receptor, and an imperfect WSXWS box (WGEWS), which is required for protein folding and cell surface receptor binding [11], [15]. The cytoplasmic domain is short and characterised by the presence of a highly conserved proline-rich domain (PPXP), which is adjacent to the plasma membrane and involved in signal transduction (reviewed in [10]).
###end p 5
###begin p 6
###xml 260 262 252 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16">16</xref>
###xml 263 265 255 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b19">19</xref>
###xml 355 357 347 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15">15</xref>
###xml 23 28 <span type="species:ncbi:9606">human</span>
###xml 315 321 <span type="species:ncbi:10090">murine</span>
Several studies on the human GMRalpha have demonstrated that as consequence of alternative splicing or metalloproteinase activity, GMRalpha loses its tramsmembrane domain resulting in a soluble isoform, which is able to antagonise GM-CSF binding and function [16-19]. However, alternatively spliced isoforms of the murine receptor have not been reported [15].
###end p 6
###begin p 7
###xml 65 69 <span type="species:ncbi:10090">mice</span>
###xml 149 154 <span type="species:ncbi:10090">mouse</span>
###xml 285 290 <span type="species:ncbi:10090">mouse</span>
###xml 315 320 <span type="species:ncbi:10090">mouse</span>
###xml 491 496 <span type="species:ncbi:10090">mouse</span>
###xml 536 541 <span type="species:ncbi:9606">human</span>
###xml 596 601 <span type="species:ncbi:10090">mouse</span>
In spite of the obvious importance of GM-CSF and the wide use of mice in immunological studies there are no useful reagents for the detection of the mouse GMRalpha or extensive studies of its expression and function. In this report, we present a comprehensive study of GMRalpha in the mouse. We have found that the mouse GMRalpha is polymorphic and alternatively spliced. Due to the restricted availability of specific antibodies against the extracellular domain of GMRalpha, we coupled the mouse GM-CSF to the Fc fragment derived from human IgG (GM-Fc) to characterise surface expression of the mouse GMRalpha on distinct leucocyte populations. GM-Fc is able to bind and activate the receptor, and thereby, provides a novel way to examine the regulation and expression of GMRalpha during steady state and immunological challenge.
###end p 7
###begin title 8
Results
###end title 8
###begin title 9
###xml 4 9 <span type="species:ncbi:10090">mouse</span>
The mouse GM-CSF receptor is alternatively spliced and polymorphic
###end title 9
###begin p 10
###xml 110 112 106 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15">15</xref>
###xml 214 216 210 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b17">17</xref>
###xml 451 461 447 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig01">Fig. 1A, B</xref>
###xml 703 709 689 695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig01">Fig. 1</xref>
###xml 45 51 <span type="species:ncbi:10090">murine</span>
###xml 195 200 <span type="species:ncbi:9606">human</span>
###xml 368 372 <span type="species:ncbi:10090">mice</span>
Early studies on the characterisation of the murine GMRalpha failed to detect alternatively spliced isoforms [15] but a soluble receptor able to block GM-CSF function has been identified for the human counterpart [17]. Using cDNA from bone marrow cells, we identified full-length transcripts with open reading frame of 1167 bp (388 amino acids) for Balb/c and C57BL/6 mice, which are polymorphic at amino acid residue 227 (Asp and Gly, respectively) (Fig. 1A, B). We also found alternative splice forms in C57BL/6: a deletion isoform (triangle up223-247), which lacks part of the FN-III domain, and a truncated isoform that would be predicted to be soluble due to the absence of a transmembrane domain (Fig. 1). These sequences have been submitted to GenBank (accession numbers: EF114317 and EF114318).
###end p 10
###begin p 11
###xml 36 41 <span type="species:ncbi:10090">mouse</span>
###xml 219 223 <span type="species:ncbi:10090">mice</span>
###xml 239 243 <span type="species:ncbi:10090">mice</span>
###xml 570 575 <span type="species:ncbi:10090">mouse</span>
Characterisation of GMRalpha in the mouse model. (A) Schematic representation of the 11 exons coding for GMRalpha. The recently published sequence (Ensembl release 40) corresponds to the full-length sequence of C57BL/6 mice whereas Balb/c mice display a polymorphic change in exon 6. We observed two additional splice forms, one with a small deletion and a truncated form, the changes in which are shown schematically. Black arrows indicate coding exons while grey arrows indicate non-coding sequence. (B) Schematic representation of the three predicted isoforms of the mouse GMRalpha. The full-length isoform is composed of a short cytoplasmic tail, a transmembrane region and an extracellular region, which contains an FN-III domain where there is a polymorphic change at residue 227* (Asp for Balb/c and Gly for C57BL/6). The deletion transcript results in an in-frame deletion in the FN-III domain, but retains a transmembrane domain. The truncated isoform has a premature stop codon.
###end p 11
###begin p 12
###xml 50 56 46 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">csf2ra</italic>
###xml 224 231 220 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig01">Fig. 1A</xref>
###xml 522 529 518 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig01">Fig. 1A</xref>
###xml 29 34 <span type="species:ncbi:10090">mouse</span>
###xml 92 97 <span type="species:ncbi:10090">mouse</span>
The genomic structure of the mouse GMRalpha gene, csf2ra, has only recently been completed (mouse genome sequence Ensembl release 40). The transcripts we identified are shown schematically alongside this genomic sequence in Fig. 1A. The deletion isoform appears to be created by skipping of the splice acceptor of exon 6 and aberrant splicing into the coding sequence of exon 6. Similarly the truncation isoform is the result of inclusion of the fifth intron into the final transcript resulting in a premature stop codon (Fig. 1A).
###end p 12
###begin title 13
###xml 51 56 <span type="species:ncbi:10090">mouse</span>
Functional analysis of polymorphic variants of the mouse GM-CSF receptor
###end title 13
###begin p 14
###xml 141 143 134 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b14">14</xref>
###xml 542 544 524 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b20">20</xref>
###xml 63 67 <span type="species:ncbi:10090">mice</span>
We expressed full-length GMRalpha from both Balb/c and C57BL/6 mice in Ba/F3 cells, which constitutively express both AIC2A and AIC2B betac [14], permitting the generation of a functional alphabeta receptor, which should respond to GM-CSF. We cultured Ba/F3 cells (transduced with empty vector or GMRalpha-encoding vectors) in the presence of IL-3 or GM-CSF, and assessed cell proliferation daily by determining the percentage of reduction of Alamarblue, an oxidation-reduction indicator that changes color in response to metabolic activity [20].
###end p 14
###begin p 15
###xml 253 260 245 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig02">Fig. 2A</xref>
###xml 675 682 655 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig02">Fig. 2B</xref>
We found that empty vector-transduced control cells (Ba/F3:pFB), like untransduced Ba/F3 cells (data not shown), proliferated only in the presence of IL-3, but GMRalpha-transduced Ba/F3 cells (Ba/F3:GMRalpha) could proliferate in either IL-3 or GM-CSF (Fig. 2A). Using these conditions, we were able to detect significant proliferation of Ba/F3:GMRalpha after 5 days in culture with a concentration of GM-CSF as low as 0.032 ng/mL. Since we did not have a reagent to monitor expression of the polymorphic forms of GMRalpha, we calculated a ratio of proliferation to compare the functional activity of the polymorphic variants of GMRalpha in response to both GM-CSF and IL-3 (Fig. 2B). We found a similar proliferation ratio for both polymorphic forms of GMRalpha, indicating that the polymorphism does not affect responsiveness of the cell to GM-CSF.
###end p 15
###begin p 16
###xml 97 101 <span type="species:ncbi:10090">mice</span>
Functionality of polymorphic forms of GMRalpha. (A) Full-length GMRalpha from Balb/c and C57BL/6 mice were retrovirally transduced into Ba/F3 cells. Ba/F3 cells transduced with empty vector or GMRalpha-encoding vectors were cultured in the presence of 4 ng/mL of GM-CSF (filled circles) or IL-3 (open circles) for the indicated number of days (left panels) or in the indicated concentrations of cytokine for 8 days (right panels). Cell proliferation was measured by determining the percentage of reduction of Alamarblue. (B) The ratio of proliferation in response to GM-CSF and IL-3 was calculated to compare the polymorphic variants; filled squares: Ba/F3:pFB; open circles: Ba/F3:GMRalpha (Balb/c); filled circles: Ba/F3:GMRalpha (C57BL/6).
###end p 16
###begin title 17
A novel GM-CSF chimeric protein and assessment of its functionality
###end title 17
###begin p 18
###xml 266 276 262 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig03">Fig. 3A, B</xref>
###xml 366 368 362 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b21">21</xref>
###xml 490 497 482 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig03">Fig. 3C</xref>
###xml 59 64 <span type="species:ncbi:10090">mouse</span>
###xml 207 212 <span type="species:ncbi:10090">mouse</span>
###xml 246 251 <span type="species:ncbi:9606">human</span>
The lack of antibodies against the extracellular domain of mouse GMRalpha has greatly restricted the study of this receptor. In order to circumvent this limitation, we designed a chimeric protein fusing the mouse GM-CSF to a mutated Fc region of human IgG1 (GM-Fc) (Fig. 3A, B), which contains point mutations to avoid complement activation and Fc receptor binding [21]. To evaluate the functionality of GM-Fc, we first determined its capacity to recognise Ba/F3 cells expressing GMRalpha (Fig. 3C). GM-Fc was able to bind the two polymorphic variants of GMRalpha (Balb/c and C57BL/6) while binding to cells transduced with empty vector was not detected.
###end p 18
###begin p 19
###xml 143 148 <span type="species:ncbi:10090">mouse</span>
###xml 182 187 <span type="species:ncbi:9606">human</span>
###xml 449 453 <span type="species:ncbi:10090">mice</span>
Generation and characterisation of a GM-CSF-Fc fusion protein. (A) Graphic representation of GM-Fc, a chimeric protein generated by fusing the mouse GM-CSF to a mutated Fc region of human IgG1. (B) GM-Fc purity was assessed by Coomassie blue staining of protein resolved under both reducing (R) and non-reducing (NR) conditions by 10% SDS-PAGE. (C) The binding capacity of GM-Fc (grey line) to Ba/F3 cells expressing GMRalpha from Balb/c or C57BL/6 mice was determined by FACS as indicated previously and compared to the control-Fc protein (black line).
###end p 19
###begin p 20
###xml 150 157 146 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig04">Fig. 4A</xref>
###xml 246 253 238 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig04">Fig. 4B</xref>
###xml 321 325 <span type="species:ncbi:10090">mice</span>
We next cultured Ba/F3 cells (Ba/F3:pFB and Ba/F3:GMRalpha) in presence of either GM-CSF or GM-Fc and assessed cell proliferation as indicated above (Fig. 4A). Similarly to GM-CSF, GM-Fc was effective at inducing proliferation of Ba/F3:GMRalpha (Fig. 4B). To determine whether the polymorphism between C57BL/6 and Balb/c mice affected binding of the cytokine, we measured the binding of the recombinant protein to both transduced cell lines. There was no marked difference in the binding between the Balb/c (KD = 15.6 nM, 95%-confidence interval: 10.9-20.3) and C57BL/6 (KD = 19.6 nM, 95%-confidence interval: 15.6-23.6) forms of the receptor.
###end p 20
###begin p 21
Effect of GM-Fc on Ba/F3 cells expressing full-length GMRalpha isoforms. (A) Ba/F3:pFB (filled squares), Ba/F3:GMRalpha (Balb/c; open circles), and Ba/F3:GMRalpha (C57BL/6; filled circles) were cultured in the presence of either GM-CSF or GM-Fc and cell proliferation was determined using Alamarblue as indicated previously. (B) Expressing percentage Alamarblue reduction obtained when GM-Fc or GM-CSF was used as a growth factor as a ratio shows that both agents have a similar capacity to support proliferation of Ba/F3:GMRalpha cells. (C) The ability of the C57BL/6 and Balb/c isoforms of GMRalpha to bind to the cytokine was assessed using GM-Fc and analysed by non-linear regression. Data shown represent pooled data from two independent experiments, and error bars shown the SEM.
###end p 21
###begin title 22
Functional activity of the alternative splice forms of GMRalpha
###end title 22
###begin p 23
###xml 199 206 191 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig05">Fig. 5A</xref>
###xml 573 580 557 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig05">Fig. 5B</xref>
We next assessed the functional activity of the alternative splice forms of GMRalpha. Ba/F3 cells, stably transduced with the deletion and truncation isoforms of GMRalpha, were unable to bind GM-Fc (Fig. 5A). We verified this by culturing Ba/F3 cells expressing either the deletion or the truncation GMRalpha isoform in the presence of IL-3, GM-CSF or GM-Fc. Only those cells expressing the full-length GMRalpha proliferated in the presence of GM-CSF or GM-Fc. The cells expressing the deletion or truncation isoforms were only able to proliferate in the presence of IL-3 (Fig. 5B).
###end p 23
###begin p 24
###xml 199 203 <span type="species:ncbi:10090">mice</span>
Effect of GM-Fc on Ba/F3 cells expressing the deletion and truncation GMRalpha isoforms. (A) The binding capacity of GM-Fc to Ba/F3 cells expressing the deletion and truncation GMRalpha from C57BL/6 mice was determined by FACS as indicated previously. (B) Ba/F3:pFB, Ba/F3:GMRalpha (C57BL/6), the deletion and truncation isoforms (C57BL/6) were cultured in the presence of either GM-CSF, GM-Fc, or IL-3-conditioned medium or in the absence of cytokine. Cell proliferation was determined using Alamarblue as indicated previously.
###end p 24
###begin title 25
Detection of GMRalpha on the surface of primary leukocytes
###end title 25
###begin p 26
###xml 77 79 73 75 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b22">22</xref>
###xml 343 349 331 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig06">Fig. 6</xref>
###xml 388 392 376 380 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 395 399 383 387 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 404 405 392 393 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;</sup>
###xml 423 426 411 414 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">low</sup>
###xml 429 435 417 423 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v.high</sup>
###xml 440 441 428 429 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 463 464 451 452 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 467 468 455 456 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 471 475 459 463 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 502 503 490 491 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 512 513 500 501 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;</sup>
###xml 528 531 516 519 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">low</sup>
###xml 536 537 524 525 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 542 543 530 531 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 629 639 613 623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig06">Fig. 6A, B</xref>
###xml 660 661 644 645 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 677 678 661 662 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;</sup>
###xml 683 684 667 668 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 703 704 687 688 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 734 741 714 721 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig06">Fig. 6C</xref>
###xml 779 784 759 764 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">W117A</sup>
###xml 983 990 963 970 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table 1</xref>
###xml 1136 1142 1112 1118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig06">Fig. 6</xref>
###xml 1147 1154 1123 1130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table 1</xref>
###xml 64 69 <span type="species:ncbi:9606">human</span>
###xml 130 135 <span type="species:ncbi:10090">mouse</span>
###xml 1048 1053 <span type="species:ncbi:9606">human</span>
Cell surface expression of GMRalpha has been broadly studied in human cells [22], but little is known about its expression in the mouse model. We used GM-Fc to detect GMRalpha in different cell populations in blood, bone marrow and spleen. A detailed analysis of GMRalpha expression by the cell populations in peripheral blood is presented in Fig. 6. All populations of granulocytes (Gr-1highSSChighF4/80- neutrophils, Gr-1lowSSCv.highF4/80+ eosinophils and CD49b+IgE+SSChigh basophils) as well as Gr-1+ and Gr-1- monocytes (SSClowF4/80+CD11b+) expressed similar levels of GMRalpha, with monocytes expressing the highest levels (Fig. 6A, B), while T cells (CD3+), NK cells (CD3-CD49b+) and B cells (CD19+) lacked GMRalpha expression (Fig. 6C). The control-Fc chimeric protein (CRW117A-Fc) was unable to bind either myeloid or lymphoid cells confirming the specificity of GM-Fc binding. The expression data from spleen and bone marrow are compared to those of blood and summarised in Table 1. Consistent with the expression pattern reported for the human homologue, we found that myeloid cells but not lymphoid cells expressed GMRalpha (Fig. 6 and Table 1).
###end p 26
###begin p 27
###xml 226 230 218 222 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 233 241 225 233 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">int&#8211;high</sup>
###xml 310 314 302 306 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 317 321 309 313 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 360 363 352 355 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">low</sup>
###xml 366 372 358 364 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v.high</sup>
###xml 413 414 405 406 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 417 418 409 410 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 653 654 645 646 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 659 660 651 652 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 703 706 695 698 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">low</sup>
###xml 1012 1013 1000 1001 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1053 1054 1041 1042 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;</sup>
###xml 1059 1060 1047 1048 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1103 1104 1091 1092 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 85 90 <span type="species:ncbi:10090">mouse</span>
Detection of GMRalpha on the surface of blood leukocytes. Cell surface expression of mouse GMRalpha in different blood cell populations was determined by FACS using GM-Fc or control-Fc. (A) Granulocytes were gated by their SSChighFSCint-high phenotype (left panel 1), and subdivided into neutrophils (Neu, Gr-1highSSChigh; left panel 2), eosinophils (Eos, Gr-1lowSSCv.high; left panel 2) and basophils (Bas, CD49b+IgE+; left panel 3). Binding of control-Fc (middle panels) and GM-Fc (right panels) was then assessed on the three populations as indicated. GM-Fc bound to all three granulocyte populations (B) Monocytes (Mo) were identified by their F4/80+CD11b+ phenotype (left panel) after gating on SSClow cells (not shown). The monocytes were further divided by their expression of Gr-1 and assessed for binding of control-Fc (middle panel) or GM-Fc (right panel). GM-Fc bound well to both major monocyte subsets. (C) GMRalpha expression was also determined on lymphoid cells. T cells (top panels, gated on CD3+), NK cells (middle panels, gated on CD3-CD49b+) and B cells (bottom panels, gated on CD19+) were assessed for binding of GM-Fc (grey lines) and control-Fc (black line). No specific binding of GM-Fc was detected on the lymphocyte populations.
###end p 27
###begin p 28
###xml 41 46 <span type="species:ncbi:10090">mouse</span>
Summary of the expression of GMRalpha by mouse leukocytes
###end p 28
###begin p 29
+ denotes GMRalpha expression; - denotes absence of detectable GMRalpha expression; ND denotes not detectable or not determined.
###end p 29
###begin p 30
###xml 32 33 32 33 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 42 43 42 43 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;</sup>
Refers collectively to both Gr-1+ and Gr-1- monocytes.
###end p 30
###begin p 31
Splenic macrophages are identified by autofluorescence and F4/80 expression, whereas peritoneal macrophages also express high levels of CD11b.
###end p 31
###begin p 32
Dendritic cell-like cells in the peritoneal cavity express relatively low levels of CD11c.
###end p 32
###begin title 33
Expression of GMRalpha on macrophages
###end title 33
###begin p 34
###xml 290 297 286 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig07">Fig. 7A</xref>
###xml 363 370 355 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig07">Fig. 7A</xref>
Since GM-CSF plays an important role in the production and function of macrophages, we analysed the expression of GMRalpha on inflammatory-elicited peritoneal macrophages and on alveolar macrophages. Macrophages elicited by intraperitoneal administration of thioglycollate broth or biogel (Fig. 7A) exhibited high levels of GMRalpha, as did alveolar macrophages (Fig. 7A). Injection of thioglycollate broth or biogel recruited neutrophils and eosinophils. These cells also expressed GMRalpha but the levels of receptor were lower than in the inflammatory macrophages (data not shown).
###end p 34
###begin p 35
###xml 720 721 712 713 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 724 725 716 717 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 751 752 743 744 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 997 998 989 990 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1007 1008 999 1000 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1138 1139 1122 1123 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1423 1427 1407 1411 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 1432 1436 1416 1420 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 1499 1502 1483 1486 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">low</sup>
###xml 1507 1511 1491 1495 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 1612 1617 1596 1601 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
Expression of GMRalpha by macrophages and characterisation of myeloid cells. (A) Inflammatory peritoneal macrophages were elicited by intraperitoneal administration of thioglycollate broth (top panels) or biogel (middle panels) for 4 days. GMRalpha expression was analysed by FACS along with the macrophages identified by F4/80 and CD11b profiles (gated regions). Alveolar macrophages were isolated from lung lavage and gated in accordance with the expression of F4/80 and CD11c (bottom panels). GM-Fc (right panels, grey lines), when compared to control-Fc (right panels, black lines), bound specifically and at high levels to the macrophage populations. (B) RAW264.7 cells were stimulated with 100 ng/mL poly(I:C), Pam3CSK4, flagellin or LPS or 5x106 particles/well of zymosan. After 24 h, binding of GM-Fc was assessed by FACS. Data represent the results of four independent experiments and error bars are the SD. Data were analysed by repeated measures one-way ANOVA with Dunnet's post test; *p<0.05, **p<0.01. (C) We used GM-Fc to identify GMRalpha-expressing cells in the resting peritoneal cavity (upper panels). Gating on GMRalpha+ cells identified three populations of myeloid cells, which expressed distinct levels of the myeloid markers CD11b and F4/80 (populations 1-3, upper right panel). The physical FSC/SCC profiles of three populations are shown in the lower panels. Population 1 exhibits the classic F4/80highCD11bhigh phenotype of resident peritoneal macrophages. The second F4/80lowCD11bhigh population also expressed MHC class II and exhibited dendritic cell-like characteristics (Dioszeghy et al., manuscript in preparation) and the third rarer population shared the phenotype of eosinophils.
###end p 35
###begin p 36
###xml 413 414 401 402 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 417 418 405 406 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 491 498 479 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig07">Fig. 7B</xref>
###xml 103 108 <span type="species:ncbi:10090">mouse</span>
To determine changes in the expression of GMRalpha following stimulation, we treated RAW264.7 cells (a mouse macrophage-like cell line expressing high levels of GMRalpha on their cell surface) with a range of inflammatory insults and assessed binding of GM-Fc. We found that RAW264.7 cells selectively up-regulated GMRalpha surface expression in response to a variety of Toll-like receptor agonists, including Pam3CSK4, flagellin, lipopolysaccharide (LPS) and zymosan, but not to poly(I:C) (Fig. 7B).
###end p 36
###begin title 37
Expression of GMRalpha as a marker of myeloid cells
###end title 37
###begin p 38
###xml 340 342 332 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b23">23</xref>
###xml 568 569 552 553 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;</sup>
###xml 150 155 <span type="species:ncbi:10090">mouse</span>
The restriction of GMRalpha to cells of the myeloid, but not lymphoid, lineage indicated that GMRalpha may be a useful marker of myeloid cells in the mouse. The peritoneal cavity contains a variety of immune cells, which have traditionally been considered as the first line of defence against invasion of micro-organisms in the peritoneum [23]. We used GM-Fc to identify GMRalpha-expressing cells in the resting peritoneal cavity, and the positive population was further analysed by expression of the additional myeloid markers F4/80 and CD11b. The peritoneal GMRalpha- cells corresponded predominantly to lymphocytes, mainly B cells (data not shown).
###end p 38
###begin p 39
###xml 66 73 66 73 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig07">Fig. 7C</xref>
###xml 216 220 216 220 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 225 229 225 229 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 247 254 247 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig07">Fig. 7C</xref>
###xml 396 403 396 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig07">Fig. 7C</xref>
###xml 599 603 599 603 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 614 617 614 617 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">low</sup>
###xml 802 803 802 803 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 893 898 893 898 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 571 576 <span type="species:ncbi:10090">mouse</span>
###xml 831 835 <span type="species:ncbi:10090">mice</span>
We were able to clearly differentiate three distinct populations (Fig. 7C). The most common population representing about 30-40% of peritoneal cells had the classic phenotype of resident peritoneal macrophages (CD11bhighF4/80high, population 1 in Fig. 7C). A sparse population, which expressed moderate levels of both CD11b and F4/80, had high SSC and shared additional markers with eosinophils (Fig. 7C and data not shown). Most interesting was the identification of an apparently novel cell type, which represented between 1 and 5% of the peritoneal cells depending on mouse strain and had a CD11bhigh, but F4/80low phenotype. We subsequently purified and began the functional characterisation of these cells. They express high levels of MHC class II and can present antigen to ovalbumin-specific CD4+ T cells from naive DO11.10 mice indicative of a dendritic cell-like phenotype (Dioszeghy et al., manuscript in preparation).
###end p 39
###begin title 40
Discussion
###end title 40
###begin p 41
###xml 134 136 130 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b24">24</xref>
###xml 140 142 136 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b25">25</xref>
###xml 174 176 167 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b26">26</xref>
###xml 180 182 173 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b27">27</xref>
###xml 222 224 215 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b28">28</xref>
###xml 225 227 218 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b30">30</xref>
###xml 278 280 271 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b31">31</xref>
###xml 284 286 277 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b32">32</xref>
###xml 34 39 <span type="species:ncbi:9606">human</span>
###xml 106 110 <span type="species:ncbi:10090">mice</span>
###xml 407 412 <span type="species:ncbi:10090">mouse</span>
The structure and function of the human GMRalpha has been broadly investigated, and several studies using mice lacking either GM-CSF [24], [25] or the betac of its receptor [26], [27], as well as administration of GM-CSF [28-30] or neutralising antibodies against the cytokine [31], [32] have been used in models of disease. However, fundamental knowledge about the nature of expression and function of the mouse GMRalpha is lacking.
###end p 41
###begin p 42
###xml 490 497 478 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table 1</xref>
###xml 1027 1029 1007 1009 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15">15</xref>
###xml 75 79 <span type="species:ncbi:10090">mice</span>
###xml 95 100 <span type="species:ncbi:10090">mouse</span>
###xml 645 649 <span type="species:ncbi:10090">mice</span>
In this study, we cloned GMRalpha-coding sequences from Balb/c and C57BL/6 mice. We found that mouse GMRalpha is polymorphic at amino acid residue 227 (Asp and Gly, respectively) and alternatively spliced. As well as amplifying full-length clones, we identified two alternatively spliced isoforms that have not been previously described. These alternatively spliced isoforms were expressed in bone marrow cells, where the predominant expression of GMRalpha is by neutrophils and monocytes (Table 1). We retrovirally transduced the IL-3-dependent AIC2A/AIC2B-expressing Ba/F3 cell line with the full-length GMRalpha clones from Balb/c or C57BL/6 mice. The Ba/F3:GMRalpha cells were able to proliferate in response to GM-CSF, unlike the control vector-transduced cells, and comparative analysis of the responses to cell lines to IL-3 and GM-CSF indicated that the polymorphism did not significantly affect receptor function. Apart from the polymorphic residue mentioned above, our sequences were identical to the published cDNA [15].
###end p 42
###begin p 43
###xml 196 202 192 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig03">Fig. 3</xref>
###xml 790 798 774 782 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 803 810 787 794 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 60 65 <span type="species:ncbi:10090">mouse</span>
###xml 145 150 <span type="species:ncbi:10090">mouse</span>
###xml 184 189 <span type="species:ncbi:9606">human</span>
###xml 902 908 <span type="species:ncbi:10090">murine</span>
Since there are no commercial reagents for the detection of mouse GMRalpha at the cell surface, we designed a chimeric protein (GM-Fc) which had mouse GM-CSF fused to the Fc domain of human IgG1 (Fig. 3). GM-Fc bound specifically to GMRalpha-transduced Ba/F3, but not control transduced cells, confirming its specificity as a receptor-detecting reagent. However, GM-Fc was not suitable for immunohistochemical analysis of the expression of GMRalpha in fixed tissue sections, most likely because of the need for heterodimeric receptor for high-affinity binding. GM-Fc was also able to support the proliferation of the GMRalpha-transduced Ba/F3 cells, indicating that the reagent functioned in a comparable way to the natural cytokine making possible its implementation in functional studies in vitro and in vivo. GM-Fc was thus a specific and sensitive immunological tool to study the expression of the murine GMRalpha on a variety of cell types.
###end p 43
###begin p 44
###xml 87 93 83 89 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig01">Fig. 1</xref>
###xml 263 265 259 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16">16</xref>
###xml 269 271 265 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b17">17</xref>
###xml 380 387 376 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig05">Fig. 5A</xref>
###xml 576 582 562 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig01">Fig. 1</xref>
###xml 723 730 709 716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig05">Fig. 5A</xref>
###xml 996 998 978 980 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b33">33</xref>
###xml 11 16 <span type="species:ncbi:10090">mouse</span>
###xml 120 125 <span type="species:ncbi:9606">human</span>
One of the mouse GMRalpha isoforms lacked the transmembrane region (truncated isoform, Fig. 1), which by analogy to the human receptor isoforms could be secreted into the extracellular environment as a soluble receptor capable of antagonizing receptor functions [16], [17]. Consistent with this we were unable to detect this isoform on the surface of transduced cells with GM-Fc (Fig. 5A). The second isoform contained a deletion (triangle up223-247) within the FN-III domain, but had an intact transmembrane domain and would be predicted to be expressed at the cell surface (Fig. 1). We were unable to detect GM-Fc binding on cells transduced to express this isoform, suggesting that it was incapable of cytokine binding (Fig. 5A). The biological relevance of these isoforms remains to be established but they could be significant in the regulation of GMRalpha expression and in the study of diseases associated with deficiency of GM-CSF:GM-CSF receptor, such as pulmonary alveolar proteinosis [33].
###end p 44
###begin p 45
###xml 178 180 174 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b34">34</xref>
###xml 356 357 348 349 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 366 367 358 359 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;</sup>
###xml 1009 1011 989 991 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b35">35</xref>
###xml 1012 1014 992 994 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b37">37</xref>
###xml 1268 1270 1244 1246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b38">38</xref>
###xml 1274 1276 1250 1252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b39">39</xref>
###xml 137 142 <span type="species:ncbi:10090">mouse</span>
###xml 165 170 <span type="species:ncbi:9606">human</span>
###xml 771 776 <span type="species:ncbi:9606">human</span>
We have used GM-Fc for the first sensitive assessment of the surface expression of GMRalpha on primary leucocytes derived from different mouse tissues. Similarly to human cells [34], macrophages [alveolar and peritoneal, both resident and inflammatory (thioglycollate- or biogel-elicited)], were the highest GMRalpha- expressing cells followed by both Gr-1+ and Gr-1- monocytes (from blood, spleen and bone marrow). Neutrophils and eosinophils (from blood, spleen, bone marrow and peritoneal lavage) as well as circulating basophils expressed reasonable levels of GMRalpha but less than those expressed by macrophages or dendritic cells. Lymphoid cells (B cells, T cells and NK cells) derived from blood, spleen and bone marrow did not express GMRalpha. In the same way, human lymphocytes (B cells, T cells and NK cells) do not express GMRalpha but its presence has been demonstrated in some malignancies like the hairy-cell leukaemia, breast and lung carcinomas as well as on several hemopoietic cell lines [35-37]. These data are also consistent with studies on hematopoietic commitment and differentiation, which have revealed that GMRalpha expression contributes to the development of myeloid cells while its expression impacts negatively on the lymphoid lineage [38], [39].
###end p 45
###begin p 46
###xml 451 452 447 448 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 455 456 451 452 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
We were unable to detect expression on non-hemopoietic cell lines such as b.END-3, NIH3T3 and, perhaps more interestingly given the role of GM-CSF in the lung homeostasis, LA-4 respiratory epithelial cells (data not shown). We extended these studies by applying GM-Fc to the study of the macrophage inflammatory response by determining changes in the surface expression of GMRalpha in response to microbial stimuli. The Toll-like receptor agonists Pam3CSK4, flagellin, zymosan and LPS all induced an up-regulation of GMRalpha surface expression, validating the use of GM-Fc as a sensitive way to monitor the regulation of GMRalpha expression by immune cells.
###end p 46
###begin p 47
###xml 161 163 161 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b23">23</xref>
###xml 424 431 420 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig07">Fig. 7C</xref>
###xml 561 563 557 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b40">40</xref>
###xml 611 615 607 611 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 620 623 616 619 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">low</sup>
###xml 841 846 837 842 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1037 1045 1033 1041 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1063 1065 1059 1061 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b30">30</xref>
###xml 1069 1071 1065 1067 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b41">41</xref>
###xml 1075 1077 1071 1073 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b42">42</xref>
###xml 1175 1177 1171 1173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b43">43</xref>
We were interested in the resident cells dwelling in the peritoneal cavity, which are thought to be essential in the local defensive response against infection [23]. The peritoneal cavity has been extensively exploited to study inflammation but the resident myeloid cells have not been well characterised. We defined three populations of GMRalpha-expressing cells in the peritoneal cavity by their CD11b and F4/80 profiles (Fig. 7C). The major population, representing 30-40% of the normal peritoneal cells, had the classic phenotype of peritoneal macrophages [40]. We also identified a second population (CD11bhighF4/80low), not previously described, which after further functional analysis appears to comprise dendritic-like cells, as determined by the expression of MHC class II and ability to present antigen to naive T cells (Dioszeghy et al., manuscript in preparation). Several studies have suggested the presence of dendritic cells in the peritoneal cavity but they have demonstrated a capacity to demonstrate antigen only after in vitro differentiation [30], [41], [42]. The third and rarest population shared an antigen phenotype with eosinophils (data not shown) [43].
###end p 47
###begin p 48
###xml 45 50 <span type="species:ncbi:10090">mouse</span>
###xml 324 329 <span type="species:ncbi:10090">mouse</span>
###xml 373 378 <span type="species:ncbi:9606">human</span>
###xml 484 490 <span type="species:ncbi:10090">murine</span>
Taken together, this characterisation of the mouse GMRalpha as well as its expression on leukocytes from different tissues provides fundamental information that can be applied to many immunological studies. The receptor is polymorphic and importantly alternatively spliced, indicating that the regulation of its function in mouse models of disease may be as complex as its human counterpart. In the absence of antibodies, GM-Fc provides a sensitive and specific tool for the study of murine GMRalpha and its regulation during immunological challenge.
###end p 48
###begin title 49
Materials and methods
###end title 49
###begin title 50
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice and reagents
###end title 50
###begin p 51
###xml 477 479 477 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b44">44</xref>
###xml 657 658 657 658 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">l</sc>
###xml 1184 1186 1180 1182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b45">45</xref>
###xml 1217 1219 1213 1215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b46">46</xref>
###xml 19 23 <span type="species:ncbi:10090">mice</span>
###xml 151 156 <span type="species:ncbi:10090">Mouse</span>
###xml 389 393 <span type="species:ncbi:9913">calf</span>
###xml 1259 1264 <span type="species:ncbi:9606">human</span>
Balb/c and C57BL/6 mice were obtained from our own breeding colonies, kept and handled in accordance with institutional and UK Home Office guidelines. Mouse recombinant GM-CSF and IL-3 were obtained from R&D Systems, Inc. (Minneapolis, MN). IL-3-conditioned medium was derived by culture of IL-3-producing WEHI-3 cells in RPMI 1640 (Gibco, UK) supplemented with 10% heat-inactivated fetal calf serum (FCS). RAW264.7, b.END-3, NIH3T3 and LA-4 cells (a gift from Dr. T. Tuthill [44]), were used as models of macrophages, endothelial cells, fibroblasts and respiratory epithelial cells, respectively. They were cultured in DMEM supplemented with 10% FCS, 2 mM l-glutamine, penicillin and streptomycin (b.END-3 cells were also supplemented with 1% w/v non-essential amino acids, 5 microM 2-mercaptoethanol and 1 mM sodium pyruvate). Anti-IgE labelled with fluorescein isothiocyanate (FITC), anti-CD19 labelled with R-phycoerythrin (PE), and anti-F4/80-PE antibodies were purchased from Serotec (Oxford, UK). Anti-CD49b (DX5)-PE and anti-Gr-1-PE were obtained from BD Pharmingen (Franklin Lakes, NJ). Anti-CD3-FITC was from Caltag Medsystems (Buckingham, UK). Anti-CD11b-FITC (clone 5C6) [45] and anti-CD11c (clone N418) [46] were produced in our laboratory. Anti-human-Fc labelled with allophycocyanin or PE were purchased from Jackson Immunoresearch Laboratories, Inc.
###end p 51
###begin title 52
Generation of GMRalpha-stable cell lines
###end title 52
###begin p 53
###xml 67 71 <span type="species:ncbi:10090">mice</span>
###xml 791 797 <span type="species:ncbi:10090">murine</span>
RNA was isolated from bone marrow cells of both Balb/c and C57BL/6 mice according to standard conditions of the RNAeasy spin protocol (Qiagen). cDNA synthesis was performed using the Advantage RT-PCR kit (BD Biosciences) and GMRalpha was amplified by PCR with the following primers (Sigma): AGAGGAATTCCACCATGACGTCATCACATGCCATG-5' and AGAGGAATTCTAGGGCTGCAGGAGGTCCTT-3'. PCR products were cloned into pCR3.1 vector (Invitrogen Life Technologies) and sequenced (Sir William Dunn School of Pathology sequencing service). GMRalpha isoforms were further subcloned into the retroviral vector pFB(neo) (Stratagene) and transfected into the HEK293T-based Phoenix ecotropic packaging cells using FuGene 6 (Roche). Retroviral supernatants were collected after 48 h and used to transduce Ba/F3 cells, a murine IL-3-dependent pro-B cell line. Stable cell lines were selected and maintained in 0.6 mg/mL geneticin (Sigma-Aldrich).
###end p 53
###begin title 54
Proliferation assay
###end title 54
###begin p 55
Ba/F3 cells transduced with either empty vector, the full-length isoforms (Balb/c or C57BL/6), or the deletion or truncation isoforms (C57BL/6) of the GMRalpha were cultured in RPMI 1640 (Gibco) supplemented with 10% heat-inactivated FCS and the indicated concentration of cytokines (GM-CSF or IL-3). Experiments were performed in 96-well plates using an initial cell density of 1000 cells per well in a final volume of 200 muL with 10% v/v Alamarblue (Serotec). Absorbance was measured at a wavelength of 570 nm and 600 nm daily during 8 days. Percentage reduction of Alamarblue as a measure of proliferation was determined according to the manufacturer's instructions.
###end p 55
###begin title 56
Generation of GM-CSF-Fc
###end title 56
###begin p 57
###xml 183 186 183 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Eco</italic>
###xml 409 411 405 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b21">21</xref>
###xml 512 514 508 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b21">21</xref>
###xml 363 368 <span type="species:ncbi:9606">human</span>
###xml 623 626 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 800 806 <span type="species:ncbi:9913">bovine</span>
GM-CSF was amplified by PCR using the following primers (Sigma): GGGGAATTCATGTGGCTGCAGAATTTACTTTTCCT-5' and GGGGAATTCTTTTTGGCCTGGTTTTTTGCATTCAAA-3'. The PCR product was digested with EcoRI and cloned in the correct reading frame of a pSecTag2(C) vector (Invitrogen, UK), which contains the Igkappa signal peptide and was previously modified by the insertion of a human IgG1 Fc domain with its own stop codon [21]. This Fc domain contains four mutations that remove Fc receptor binding and complement activation [21]. The resultant vector encoded a GM-CSF-Fc chimeric protein (referred to as GM-Fc) under the control of the CMV promoter. GM-Fc was transfected into HEK293T cells using GeneJuice (Novagen, UK), and stable clones producing GM-Fc were selected in DMEM (Gibco) containing 4% IgG-depleted bovine serum and 0.2 mg/mL zeocin (Invitrogen Life Technologies).
###end p 57
###begin p 58
###xml 34 39 34 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BamHI</italic>
###xml 498 504 <span type="species:ncbi:9913">bovine</span>
GM-Fc was also subcloned into the BamHI restriction site of pFB(neo) (Stratagene) subsequent to PCR amplification of GM-Fc using the following primers: GGAGGATCCACCATGTGGCTGCAGAATTTACTT-5' and GGAGGATCCTCATTTACCCGGAGACAGGG-3'. This construct was transfected into HEK293T-based Phoenix ecotropic packaging cells and the retrovirus-containing medium was used to transduce NIH3T3 cells as previously described. Stable cell lines were selected and maintained in DMEM (Gibco) containing 4% IgG-depleted bovine serum and 0.6 mg/mL geneticin (Sigma-Aldrich).
###end p 58
###begin p 59
###xml 608 613 608 613 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">W117A</sup>
###xml 804 806 804 806 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b21">21</xref>
HEK293T or NIH3T3 cells expressing GM-Fc were left to condition media (above) for at least 7 days. GM-Fc was isolated by affinity purification on Protein A-sepharose (GE Healthcare) and eluted with 0.1 M glycine, pH 2.9. After neutralisation with 0.1 volume of 1 M Tris, pH 9.5, GM-Fc was dialysed against PBS and protein concentration determined by the bicinchoninic acid method (Pierce). The purity of individual batches of GM-Fc was assessed by Coomassie blue staining of protein resolved under both reducing and non-reducing conditions by 10% SDS-PAGE. To establish that binding of GM-Fc was specific, CRW117A-Fc was utilized as control-Fc protein since it contains a mutated version of the cysteine-rich domain (CR) of the mannose receptor that abrogates lectin activity and lacks binding capacity [21].
###end p 59
###begin title 60
FACS experiments and analysis
###end title 60
###begin p 61
###xml 333 334 325 326 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 497 498 481 482 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 757 758 735 736 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 287 293 <span type="species:ncbi:9986">rabbit</span>
###xml 586 591 <span type="species:ncbi:9606">human</span>
###xml 714 717 <span type="species:ncbi:10116">rat</span>
###xml 829 832 <span type="species:ncbi:10116">rat</span>
###xml 854 859 <span type="species:ncbi:9606">human</span>
###xml 891 894 <span type="species:ncbi:10116">rat</span>
###xml 900 905 <span type="species:ncbi:10090">mouse</span>
The binding of GM-Fc to GMRalpha-expressing cells (GMRalpha- transduced Ba/F3 cells or cells derived from blood, spleen, bone marrow as well as alveolar and peritoneal lavage) was determined by FACS. Briefly, cells were incubated in blocking buffer 1 (PBS containing 5% heat-inactivated rabbit serum, 0.5% BSA, 5 mM EDTA and 2 mM NaN3) for 1 h at 4degreesC. GM-Fc or control-Fc were added at 10 mug/mL in a final volume of 100 muL of washing buffer (PBS containing 0.5% BSA, 5 mM EDTA and 2 mM NaN3), and incubated for 1 h at 4degreesC. After two washes, cells were incubated with anti-human-allophycocyanin and washed again 1 h later. Cells were incubated in blocking buffer 2 (PBS containing 5% heat-inactivated rat serum, 0.5% BSA, 5 mM EDTA and 2 mM NaN3) for 1 h at 4degreesC. This step was necessary to block residual anti-rat activity of the anti-human reagent before adding labelled rat anti-mouse antibodies for the specific markers [IgE, CD19, F4/80, CD49b (DX5), Gr-1, CD3 and CD11b].
###end p 61
###begin p 62
###xml 274 277 274 277 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">med</sup>
###xml 282 283 282 283 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 288 292 288 292 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 311 315 311 315 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 320 321 320 321 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 325 328 325 328 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">low</sup>
###xml 348 351 348 351 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">med</sup>
###xml 356 357 356 357 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 360 361 360 361 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 378 381 378 381 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">med</sup>
###xml 386 387 386 387 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 390 391 390 391 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 418 419 418 419 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 428 429 428 429 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;</sup>
###xml 486 487 486 487 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 503 504 503 504 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 523 524 523 524 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;</sup>
###xml 529 530 529 530 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
After three washes, cells were resuspended in 1% formaldehyde (in PBS) and acquired on a FACScalibur (Becton Dickinson). FACS analysis was performed using FlowJo (Tree Star, Inc.). Granulocytes were gated on a FSC/SSC plot and sorted using specific markers: neutrophils (SSCmedCD11b+ Gr-1high), eosinophils (SSChighCD11b+Gr-1low) and basophils (SSCmedCD49b+IgE+). Monocytes (SSCmedCD49b+IgE+) were subdivided into GR-1+ and Gr-1- subsets, and lymphocytes were classified as T cells (CD3+), B cells (CD19+) and NK cells (CD3-CD49b+).
###end p 62
###begin title 63
Stimulation of RAW264.7 cells
###end title 63
###begin p 64
###xml 118 119 118 119 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">l</sc>
###xml 259 260 259 260 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 263 264 263 264 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 299 300 299 300 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 543 544 537 538 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 587 594 575 582 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ</italic>
###xml 508 514 <span type="species:ncbi:9986">rabbit</span>
RAW264.7 cells were seeded on 24-well plates at a density of 50 000 cells per well in DMEM supplemented with 10% FCS, l-glutamine, penicillin and streptomycin. Next day, the medium was removed and cells were cultured in presence of 100 ng/mL of poly(I:C), Pam3CSK4, flagellin, LPS or zymosan at 5x106 particles per well. Cells were incubated at 37degreesC for 24 h in presence of the stimuli. After this time, cells were washed with PBS and incubated with blocking buffer (PBS containing 5% heat-inactivated rabbit serum, 0.5% BSA and 2 mM NaN3) for 1 h at 4degreesC. Cells were stained in situ using GM-Fc or control-Fc (as described above). After staining, the cells were lifted with a scraper and transferred to a FACS tube in 1% formaldehyde. FACS acquisition and analysis were performed as indicated above. The data from four independent experiments were analysed for statistically significant differences by one-way repeated measures ANOVA test with Dunnett's multiple comparison test using GraphPad Prism.
###end p 64
###begin title 65
Analysis of the binding of GM-Fc to GMRalpha isoforms
###end title 65
###begin p 66
###xml 285 290 <span type="species:ncbi:9606">human</span>
For analysis of the binding efficiency of GM-Fc to the polymorphic variants of GMRalpha, a range of concentrations of GM-Fc were incubated with GMRalpha-transduced Ba/F3 cells for 2 h at 4degreesC. The cells were washed and the bound protein was detected as described above using anti-human-allophycocyanin and flow cytometry. Specific binding was determined by subtraction of the non-specific binding of GM-Fc to control pFBneo-transduced Ba/F3 cells. Binding data were analysed by non-linear regression using GraphPad Prism.
###end p 66
###begin p 67
We would like to thank the staff of our animal facility for the care of the animals used in this study. We would also like to thank Dr. Tim Hughes for his help with some experiments. This work was funded by a Wellcome Trust Research Career Development Fellowship (P.R.T.) in Basic Biomedical Science (grant 070579).
###end p 67
###begin article-title 68
GM-CSF biology
###end article-title 68
###begin article-title 69
###xml 37 42 <span type="species:ncbi:9606">human</span>
Emerging applications of recombinant human granulocyte-macrophage colony-stimulating factor
###end article-title 69
###begin article-title 70
GM-CSF regulates pulmonary surfactant homeostasis and alveolar macrophage-mediated innate host defense
###end article-title 70
###begin article-title 71
###xml 87 102 <span type="species:ncbi:10090">transgenic mice</span>
GM-CSF enhances lung growth and causes alveolar type II epithelial cell hyperplasia in transgenic mice
###end article-title 71
###begin article-title 72
###xml 95 96 95 96 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Distribution of receptors for granulocyte-macrophage colony-stimulating factor on immature CD34+ bone marrow cells, differentiating monomyeloid progenitors, and mature blood cell subsets
###end article-title 72
###begin article-title 73
###xml 95 100 <span type="species:ncbi:9606">human</span>
The expression, activity and regulation of granulocyte macrophage-colony stimulating factor in human endometrial epithelial and stromal cells
###end article-title 73
###begin article-title 74
###xml 22 27 <span type="species:ncbi:9606">human</span>
Activation of JAK2 in human vascular endothelial cells by granulocyte-macrophage colony-stimulating factor
###end article-title 74
###begin article-title 75
PI3-kinase activation by GM-CSF in endothelium is upstream of JAK/STAT pathway: Role of alphaGMR
###end article-title 75
###begin article-title 76
###xml 34 42 34 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 64 69 <span type="species:ncbi:9606">human</span>
Expression of GM-CSF receptor and in vitro effects of GM-CSF on human fibroblasts
###end article-title 76
###begin article-title 77
Regulation of myeloid development and function by colony stimulating factors
###end article-title 77
###begin article-title 78
Mechanism of activation of the GM-CSF, IL-3, and IL-5 family of receptors
###end article-title 78
###begin article-title 79
Regulation of proliferation, differentiation and survival by the IL-3/IL-5/GM-CSF receptor family
###end article-title 79
###begin article-title 80
Cloning of an interleukin-3 receptor gene: A member of a distinct receptor gene family
###end article-title 80
###begin article-title 81
###xml 43 48 <span type="species:ncbi:9606">human</span>
###xml 180 186 <span type="species:ncbi:10090">murine</span>
Reconstitution of functional receptors for human granulocyte/macrophage colony-stimulating factor (GM-CSF): Evidence that the protein encoded by the AIC2B cDNA is a subunit of the murine GM-CSF receptor
###end article-title 81
###begin article-title 82
###xml 28 34 <span type="species:ncbi:10090">murine</span>
Cloning of the low-affinity murine granulocyte-macrophage colony-stimulating factor receptor and reconstitution of a high-affinity receptor complex
###end article-title 82
###begin article-title 83
###xml 50 55 <span type="species:ncbi:9606">human</span>
Identification and molecular cloning of a soluble human granulocyte-macrophage colony-stimulating factor receptor
###end article-title 83
###begin article-title 84
Molecular cloning of a soluble form of the granulocyte-macrophage colony-stimulating factor receptor alpha chain from a myelomonocytic cell line. Expression, biologic activity, and preliminary analysis of transcript distribution
###end article-title 84
###begin article-title 85
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 33 38 <span type="species:ncbi:9606">human</span>
In vitro characterization of the human recombinant soluble granulocyte-macrophage colony-stimulating factor receptor
###end article-title 85
###begin article-title 86
###xml 139 144 <span type="species:ncbi:9606">human</span>
Granulocyte-macrophage colony-stimulating factor (GM-CSF) and inflammatory stimuli up-regulate secretion of the soluble GM-CSF receptor in human monocytes: Evidence for ectodomain shedding of the cell surface GM-CSF receptor alpha subunit
###end article-title 86
###begin article-title 87
###xml 123 124 123 124 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
A new rapid and simple non-radioactive assay to monitor and determine the proliferation of lymphocytes: An alternative to [3H]thymidine incorporation assay
###end article-title 87
###begin article-title 88
Development of a specific system for targeting protein to metallophilic macrophages
###end article-title 88
###begin article-title 89
Molecular physiology of granulocyte-macrophage colony-stimulating factor
###end article-title 89
###begin article-title 90
Defense mechanisms of the peritoneal cavity
###end article-title 90
###begin article-title 91
###xml 59 63 <span type="species:ncbi:10090">mice</span>
Granulocyte/macrophage colony-stimulation factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology
###end article-title 91
###begin article-title 92
###xml 79 83 <span type="species:ncbi:10090">mice</span>
T cell functions in granulocyte/macrophage colony-stimulating factor deficient mice
###end article-title 92
###begin article-title 93
###xml 17 21 <span type="species:ncbi:10090">mice</span>
Hematopoiesis in mice lacking the entire granulocyte-macrophage colony-stimulating factor/interleukin-3/interleukin-5 functions
###end article-title 93
###begin article-title 94
###xml 96 100 <span type="species:ncbi:10090">mice</span>
Distinct changes in pulmonary surfactant homeostasis in common beta-chain- and GM-CSF-deficient mice
###end article-title 94
###begin article-title 95
###xml 25 29 <span type="species:ncbi:10090">mice</span>
###xml 65 71 <span type="species:ncbi:10090">murine</span>
Hemopoietic responses in mice injected with purified recombinant murine GM-CSF
###end article-title 95
###begin article-title 96
###xml 21 28 21 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 42 46 <span type="species:ncbi:10090">mice</span>
###xml 61 67 <span type="species:ncbi:10090">murine</span>
Effects of long-term in vivo treatment of mice with purified murine recombinant GM-CSF
###end article-title 96
###begin article-title 97
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse peritoneal cells as a reservoir of late dendritic cell progenitors
###end article-title 97
###begin article-title 98
###xml 47 53 <span type="species:ncbi:10090">murine</span>
Attenuation of airway hyperresponsiveness in a murine asthma model by neutralization of granulocyte-macrophage colony-stimulating factor (GM-CSF)
###end article-title 98
###begin article-title 99
###xml 101 104 101 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">via</italic>
###xml 34 39 <span type="species:ncbi:10090">mouse</span>
Innate immune responses to LPS in mouse lung are suppressed and reversed by neutralization of GM-CSF via repression of TLR-4
###end article-title 99
###begin article-title 100
Pulmonary alveolar proteinosis: Progress in the first 44 years
###end article-title 100
###begin article-title 101
###xml 31 36 <span type="species:ncbi:9606">human</span>
Expression and function of the human granulocyte-macrophage colony-stimulating factor receptor alpha subunit
###end article-title 101
###begin article-title 102
Granulocyte-macrophage colony-stimulating factor receptor: Stage- specific expression and function on late B cells
###end article-title 102
###begin article-title 103
Varying expression levels of colony stimulating factor receptors in disease states and different leukocytes
###end article-title 103
###begin article-title 104
CD116 (granulocyte-macrophage colony stimulating factor receptor)
###end article-title 104
###begin article-title 105
Cell-fate conversion of lymphoid-committed progenitors by instructive actions of cytokines
###end article-title 105
###begin article-title 106
Enforced granulocyte/macrophage colony-stimulating factor signals do not support lymphopoiesis, but instruct lymphoid to myelomonocytic lineage conversion
###end article-title 106
###begin article-title 107
###xml 100 107 100 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ex vivo</italic>
###xml 66 72 <span type="species:ncbi:10090">murine</span>
Pattern recognition receptors and differentiation antigens define murine myeloid cell heterogeneity ex vivo
###end article-title 107
###begin article-title 108
###xml 48 51 <span type="species:ncbi:10116">rat</span>
Morphological and functional characteristics of rat steady state peritoneal dendritic cells
###end article-title 108
###begin article-title 109
###xml 24 30 <span type="species:ncbi:10090">murine</span>
Antigen presentation by murine peritoneal cavity macrophage-derived dendritic cells
###end article-title 109
###begin article-title 110
###xml 56 62 <span type="species:ncbi:10090">murine</span>
Development and functional analysis of eosinophils from murine embryonic stem cells
###end article-title 110
###begin article-title 111
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
###xml 68 84 <span type="species:ncbi:169066">human rhinovirus</span>
Mouse respiratory epithelial cells support efficient replication of human rhinovirus
###end article-title 111
###begin article-title 112
###xml 103 111 103 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 146 153 146 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 27 33 <span type="species:ncbi:10090">murine</span>
Monoclonal antibody to the murine type 3 complement receptor inhibits adhesion of myelomonocytic cells in vitro and inflammatory cell recruitment in vivo
###end article-title 112
###begin article-title 113
###xml 36 41 <span type="species:ncbi:10090">mouse</span>
The distinct leukocyte integrins of mouse spleen dendritic cells as identified with new hamster monoclonal antibodies
###end article-title 113
###begin title 114
Abbreviations:
###end title 114
###begin p 115
beta-chain of the GM-CSF receptor
###end p 115
###begin p 116
fibronectin type III
###end p 116
###begin p 117
###xml 0 5 <span type="species:ncbi:10090">mouse</span>
###xml 13 18 <span type="species:ncbi:9606">human</span>
mouse GM-CSF-human IgG1 Fc fusion protein
###end p 117
###begin p 118
GM-CSF receptor alpha-chain
###end p 118

